NUTEX HEALTH INC. (NUTX) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | Research and Development Expense |
| Revenue | 846.72M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | (m) | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 364.27M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $846.72M | (m) | $364.27M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $879.95M | (m) | $276.23M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $875.26M | (m) | $275.63M | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $981.20M | (m) | $358.99M | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $792.19M | (m) | $238.29M | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $624.28M | (m) | $201.38M | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $479.95M | (m) | $130.62M | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $292.00M | (m) | $-9.73M | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $275.93M | (m) | $-20.22M | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $258.77M | (m) | $-25.88M | $17.62M | (m) | (m) | -1.47× | Reported |
| 2023-12-31 | (m) | $247.65M | (m) | $-31.77M | $16.32M | (m) | (m) | -1.95× | Reported |
| 2023-09-30 | (m) | $358.67M | (m) | $-11.41M | $14.94M | (m) | (m) | -0.76× | Reported |
| 2023-06-30 | (m) | $197.37M | (m) | $-439.27M | $14.25M | (m) | (m) | -30.83× | Reported |
| 2023-03-31 | (m) | $196.50M | (m) | $-440.28M | $13.77M | (m) | (m) | -31.96× | Reported |
| 2022-12-31 | (m) | $219.29M | $189.58K | $-406.60M | $12.49M | (m) | 0.09% | -32.55× | Reported |
| 2022-09-30 | (m) | $-210.74M | $4.16M | $-574.90M | (m) | (m) | -1.98% | (m) | (m) |
| 2022-06-30 | (m) | $5.81M | $4.08M | $-61.42M | (m) | (m) | 70.23% | (m) | (m) |
| 2022-03-31 | $282.91K | $22.99M | $14.37M | $-21.24M | (m) | 1.23% | 62.51% | (m) | (m) |
| 2021-12-31 | $285.88K | $18.79M | $4.03M | $-9.02M | (m) | 1.52% | 21.43% | (m) | (m) |
| 2021-09-30 | $262.91K | $13.27M | $4.03M | $-12.58M | $3.93M | 1.98% | 30.36% | -3.20× | Reported |
| 2021-06-30 | $264.47K | $8.05M | $4.16M | $-9.98M | $2.38M | 3.29% | 51.67% | -4.19× | Reported |
| 2021-03-31 | $519.10K | $3.13M | $5.58M | $-8.40M | $604.79K | 16.56% | 177.87% | -13.89× | Reported |
| 2020-12-31 | $557.26K | $1.59M | $2.57M | $-5.19M | $335.45K | 35.14% | 162.15% | -15.46× | Reported |
| 2020-09-30 | $699.59K | $1.71M | $2.31M | $-6.83M | (m) | 40.94% | 135.31% | (m) | (m) |
| 2020-06-30 | $733.53K | $1.55M | $2.17M | $-7.11M | $349.41K | 47.23% | 140.02% | -20.35× | Reported |
| 2020-03-31 | $701.73K | $1.62M | $1.26M | $-6.91M | $114.90K | 43.32% | 77.79% | -60.15× | Reported |
| 2019-12-31 | $768.10K | $1.37M | $450.05K | $-6.90M | $92.16K | 56.21% | 32.94% | -74.85× | Reported |
| 2019-09-30 | (m) | $48.90K | $120.25K | $-1.67M | $561.41K | (m) | 245.92% | -2.97× | Reported |
| 2019-06-30 | (m) | $63.93K | $120.25K | $-1.67M | $773.55K | (m) | 188.09% | -2.16× | Reported |
| 2019-03-31 | (m) | $61.36K | $209.05K | $-1.79M | $759.06K | (m) | 340.71% | -2.35× | Reported |
| 2018-12-31 | (m) | $60.22K | $208.03K | $-1.83M | $642.07K | (m) | 345.42% | -2.85× | Reported |
| 2018-09-30 | (m) | $25.71K | $74.30K | $-4.84M | $651.99K | (m) | 289.01% | -7.42× | Reported |
| 2018-06-30 | (m) | $22.14K | $273.80K | $-5.18M | $446.53K | (m) | 1236.74% | -11.61× | Reported |
| 2018-03-31 | (m) | $23.01K | $923.53K | $-5.94M | $371.69K | (m) | 4013.93% | -15.99× | Reported |
| 2017-12-31 | (m) | $23.17K | $924.33K | $-5.69M | $367.35K | (m) | 3990.01% | -15.50× | Reported |
| 2017-09-30 | (m) | (m) | (m) | $-2.27M | $25.87K | (m) | (m) | -87.75× | Reported |
| 2017-06-30 | (m) | (m) | (m) | $-1.63M | $9.87K | (m) | (m) | -165.47× | Reported |
| 2017-03-31 | (m) | (m) | (m) | $-449.87K | $-13.90K | (m) | (m) | (m) | Reported |
| 2016-12-31 | (m) | (m) | (m) | $-448.60K | $-2.58K | (m) | (m) | (m) | Reported |
| 2016-09-30 | (m) | $1.31M | (m) | $6.79K | $-321.52K | (m) | (m) | (m) | Reported |
| 2016-06-30 | (m) | $820.27K | (m) | $-446.50K | $-206.81K | (m) | (m) | (m) | Reported |
| 2016-03-31 | (m) | $578.08K | (m) | $-513.88K | $-127.23K | (m) | (m) | (m) | Reported |
| 2015-12-31 | (m) | $474.68K | (m) | $-498.98K | $-44.60K | (m) | (m) | (m) | Reported |
| 2015-09-30 | (m) | $1.21M | (m) | $-524.06K | $-9.06K | (m) | (m) | (m) | Reported |
| 2015-06-30 | (m) | $1.17M | (m) | $-635.85K | $-8.19K | (m) | (m) | (m) | Reported |
| 2015-03-31 | (m) | $1.13M | (m) | $-788.59K | $-8.57K | (m) | (m) | (m) | Reported |
| 2014-12-31 | (m) | $1.07M | (m) | $-780.37K | $-10.33K | (m) | (m) | (m) | Reported |
| 2014-09-30 | (m) | $1.11M | (m) | $-720.94K | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | $1.24M | (m) | $-694.83K | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | $1.34M | (m) | $-660.37K | $-57.33K | (m) | (m) | (m) | Reported |
| 2013-12-31 | (m) | $1.46M | (m) | $-727.38K | $-54.51K | (m) | (m) | (m) | Reported |
| 2013-09-30 | (m) | $1.44M | (m) | $-1.42M | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | $1.46M | (m) | $-1.44M | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | $1.48M | (m) | $-1.50M | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | $1.59M | (m) | $-1.57M | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | $1.81M | (m) | $-922.94K | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | $1.80M | (m) | $-977.38K | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | $1.85M | (m) | $-945.49K | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $1.78M | (m) | $-844.58K | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | $1.53M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $874.77K | (m) | $-1.35M | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIQUIDITY SERVICES INC (LQDT) | United States | $1.359B | 44.69 |
| ACV Auctions Inc. (ACVA) | United States | $1.775B | -19.26 |
| Concentrix Corp (CNXC) | United States | $1.792B | -1.31 |
| Western Union CO (WU) | United States | $1.878B | 6.06 |
| TIC Solutions, Inc. (TIC) | United States | $1.936B | -15.28 |
| QUINSTREET, INC (QNST) | United States | $0.822B | 10.19 |
| Paysign, Inc. (PAYS) | United States | $0.732B | 29.27 |
| CASS INFORMATION SYSTEMS INC (CASS) | United States | $0.696B | 17.90 |
| Priority Technology Holdings, Inc. (PRTH) | United States | $0.643B | 9.77 |
| Phreesia, Inc. (PHR) | United States | $0.621B | 63.46 |